Sobre mi

Dr. Joan-Marc Servitja is a senior researcher at the group Pathogenesis and Prevention of Diabetes, leading different projects related to islet biology and diabetes. He has also received contracts from the pharmaceutical industry in order to test novel applications of existing drugs as potential treatments for type 1 and type 2 diabetes. During the last years, he has authored more than 20 articles on diabetes research published in high impact journals. Currently, he is leading different research lines focused on the regulation of gene expression and inter-organ cross-talk in pancreatic islets with the ultimate goal to design novel therapeutic strategies for the treatment of type 2 diabetes.

Publicacions destacades

Projectes destacats

  • Inter-organ cross-talk and type 2 diabetes: effects of circulating exosomes on pancreatic islets

    Investigador/a principal: Joan Marc Servitja Duque, Anna Maria Novials Sarda
    Finançador: ISCIII Ministerio de Ciencia e Innovacion)
    Codi: PI20/00658
    Durada: 01/01/2021 - 31/12/2023
  • Benchtop NMR for Lab-On-Chip (BLOC)

    Investigador/a principal: Joan Marc Servitja Duque
    Finançador: European Union – H2020 (Programa financiador competitivo)
    Codi: 863037
    Durada: 01/01/2020 - 31/12/2022
  • BACE2, una nueva diana terapéutica para el tratamiento de la diabetes tipo 2 y la obesidad.

    Investigador/a principal: Joan Marc Servitja Duque, Anna Maria Novials Sarda
    Finançador: ISCIII Ministerio de Ciencia e Innovacion) (Programa financiador competitivo)
    Codi: PI17/00879
    Durada: 01/01/2018 - 31/12/2020
  • Nuevas estrategias para el tratamiento de la diabetes: intervención sobre el estrés de retículo endoplásmico y la inflamación inducidos por los depósitos de amiloide en el islote pancreático.

    Investigador/a principal: Joan Marc Servitja Duque, Anna Maria Novials Sarda
    Finançador: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede); Instituto de Salud Carlos III
    Codi: PI14/00447
    Durada: 01/01/2015 - 31/12/2017
  • Potential protective effects of an anti-inflammatory molecule on pancreatic beta-cells.

    Investigador/a principal: Joan Marc Servitja Duque, Anna Maria Novials Sarda
    Finançador: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede); Instituto Grifols, S.A. ; Instituto Grifols, S.A. (Participante)
    Durada: 01/01/2013